Insomnia: Updates in Medical Management. Michael Newnam M.D.
|
|
- Lewis Day
- 5 years ago
- Views:
Transcription
1 Insomnia: Updates in Medical Management Michael Newnam M.D.
2 Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep
3
4
5
6 Circadian Rhythm
7 Insomnia Dissatisfaction with quantity or quality of sleep causing daytime symptoms. (DSM-5) million chronic sleep/wake disorders More common in women 50% of elderly patients
8 National Health Interview Survey 62% of the adult population getting 7-8 hours of sleep 28% revealed sleeping less than 6 hours
9 Co-morbid conditions contributing to insomnia OSA RLS CVD DM Arthritis Chronic pain COPD Fibromyalgia Mood disorders
10 Treatment Goals To improve quantity and quality of sleep Improve daytime function
11 Factors to help guide treatment choices Symptom pattern Past treatment response Patient preference Costs Co-morbid conditions Contraindications Concurrent medications
12 Medications Benzodiazepines Benzodiazepine receptor agonists (BZA s) Melatonin agonists Antidepressants (TCA s/heterocyclics) Orexin Receptor agonists Atypical Antipsychotics Antihistamines
13 Benzo s Short Acting: Triazolam (Halcion)- 2 hour Intermediate acting: Temazepam (Restoril)- 9 hour Estazolam (Prosom) Long Acting: Quazepam (Doral)- 39 hours Fluazepam (Dalmane)
14 Off Label Benzo s Alprazolam (Xanax)- 1/2 life of 6-11 hours Clonazepam (Klonopin)- 1/2 life of hours Lorazepam (Ativan)- 1/2 life hours Diazepam (Valium)- up to 40 hours
15 Evidence Grade B with good evidence of short term effectiveness (decreased sleep latency, sleep duration)
16 Adverse Effects Psychomotor retardation Memory impairments Tolerance/Dependence Decreased REM sleep
17 Tips on the Benzo s Would not choose them 1st line unless another comorbidity like anxiety or parasomnias Stay with longer acting agents if possible Caution with Elderly Caution with opioids
18 Bezodiazapine receptor agonists (Z drugs) GABA alpha1 subunit (more specific than the nonselective Benzo s that effect multiple sites) Zolpidem (Ambien) 5-10 mg or ER mg Eszopiclone (Lunesta) 1-3 mg Zaleplon (Sonata) mg
19 Z-hypnotics
20 Melatonin Supplemental melatonin at 1-10 mg Ramelteon (Rozerem) 8mg, Melatonin agonist, very short 1/2 life for sleep onset insomnia No effect on GABA
21 TCA s/heterocyclic s Doxepin (Silenor) 6-50 mg sleep maintenance insomnia, safe in the elderly, take on empty stomach
22 Off Label TCA/Heterocyclic s Trazodone mg, 5HT2A (serotonin) Blockade and H1 antagonism, anticholinergic side effects as you increase dose Mirtazapine (Remeron) mg, H1 receptor antagonist, weight gain Amitriptyline, Imipramine, Nortryptaline anticholinergic side effects, orthostatic hypotension, slow cardiac conduction
23 Orexin Receptor Agonist Suvorexant (Belsomra) mg 30 minutes before bed Not likely to cause dependence or tolerance Costly
24 Atypical Antipsychotics Quetiapine (Seroquel) mg Olanzapine (Zyprexa) 5-20 mg Risperidone (Risperdal).05-2 mg 5Ht2 (serotonin blocker) and H1 antagonist Metabolic Syndrome SE s (weight gain, dyslipidemia, hyperglycemia)
25 Antihistamines Most OTC products use sedating antihistamines as the active ingredient (sominex, unisom, Zquil, PM products) Rapid tolerance, Residual drowsiness and anticholinergic side effects Lack evidence of efficacy Doxylamine (Unisom), Diphenhydramine (Zquil, sominex, Tylenol PM, Advil PM)
26 The public has spoken!
27 The public has spoken! Forget randomized controlled studies which drug has the most likes?
28
29
30
31 Summary Insomnia is a common disorder with multiple comorbidities Medical therapy targets neurotransmitters that regulate the sleep/wake cycle including histamine, serotonin, melatonin, orexin. Therapy should be individually tailored to the patient taking into consideration symptoms, comorbidities, costs and side effects. Adverse effects of sleep aids can include drowsiness, memory issues, anticholinergic effects, dependence, tolerance
The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationPharmacological Help for a Good Night s s Sleep. Thomas Owens, MD
Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches
More informationInsomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:
Insomnia treatment INSOMNIA OVERVIEW insomnia is defined as difficulty falling asleep, difficulty staying asleep, or waking up early in the morning and not being able to return to sleep. In general, people
More informationDisclosure. Sleep Medications in Primary Care: How to choose, what to avoid
Sleep Medications in Primary Care: How to choose, what to avoid Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP President, Fitzgerald Health Education Associates, North Andover,
More informationAvailable Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED
More informationDisclosure. Sleep Medications in Primary Care: How to choose, what to avoid
Sleep Medications in Primary Care: How to choose, what to avoid Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP President, Fitzgerald Health Education Associates, North Andover,
More informationINSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4
INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep
More informationInsomnia treatment in primary care
Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu
More informationDisclosure. Sleep Medications in Primary Care
Sleep Medications in Primary Care Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP President, Fitzgerald Health Education Associates, North Andover, MA Family Nurse Practitioner,
More information3/24/2016 DISCLOSURE STATEMENT PHARMACIST OBJECTIVES OVERVIEW TECHNICIAN OBJECTIVES PREVALENCE OF INSOMNIA THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA
DISCLOSURE STATEMENT I do not have any actual or potential conflict of interest in relation to this presentation THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA DANIELLE ROWAN, PHARMD, MBA PGY1 PHARMACY PRACTICE
More information14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III
4:45 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationAddressing Pharmacologic Issues in. DSM-5 Sleep-Wake. Insomnia. Disorders. DSM-5 Insomnia Disorder. Insomnia. Disorder
Addressing Pharmacologic Issues in David N. Neubauer, MD Associate Professor of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Baltimore, Maryland Restless Legs Syndrome Substance/
More informationAn algorithm for medication in the treatment of Complex PTSD
An algorithm for medication in the treatment of Complex PTSD Andreas Laddis, M.D. aladdis@gmail.com ESTD Conference Bern November 10, 2017 The purpose for the presentation Algorithm for medication: My
More information14. Percent
4:30 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationQuestion #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia
Evaluating Patients with Roger D. Seheult, M.D. Pulmonary Critical Care Physician - Beaver Medical Group, Redlands California Assistant Clinical Professor of Medicine - Loma Linda University School of
More informationManaging Insomnia Disorder A Review of the Research for Adults
Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said
More informationComparison of Insomnia Treatments
PL Detail-Document #280504 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER May 2012 Comparison of Insomnia
More informationSleep Disorders: Assessment and Therapeutic Options
Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor
More informationcontinuing education for pharmacists
continuing education for pharmacists General Insomnia Disorder in Adults and Treatment Guidelines Amanda R. Kriesen, R.Ph., PharmD Volume XXXV, No. 9 Dr. Amanda Kriesen has no relevant financial relationships
More informationAnxiolytic and Hypnotic drugs
Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiety is unpleasant state of tension and fear that seems to arise from unknown source. The symptoms of severe anxiety are similar to those
More informationBenzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project
Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project This project is funded through a grant from the Pew Charitable
More informationInsomnia Agents (Sherwood Employer Group)
Insomnia Agents (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf Link to
More informationInsomnia. Arturo Meade MD
Insomnia Arturo Meade MD Goals Definition Prevalence Pathophysiology The role of Orexin Orexin receptor blockers Consequences: Daily Functioning Insomnia: Consequences Decreased quality of life
More informationDrugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
More informationA Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment
A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment Jordan Pleskow, PharmD Roswell Park Cancer Institute Oncology Symposium 11/11/17 Objectives Evaluate the issues with sleep in
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationDrug Class Update: Sedatives
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationPsychopharmacology of Sleep Disorders
Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry
More informationCPT David Shaha, MC US Army
CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case
More informationSleep Disorders and Insomnia
7:45 8:45 am Management of Insomnia and Other Disorders SPEAKER Alon Y. Avidan, MD, MPH, FAAN, FAASM Presenter Disclosure Information The following relationships exist related to this presentation: Alon
More informationDisclosure. Objective 1. Objective 2. Naval Health Center New England. Objective 3. APNA 27th Annual Conference Session 1036: October 9, 2013
Understanding Sleep and Antidepressants: Lessons from Research Literature and Clinical Practice Joseph M. Holshoe, PMHNP-BC Commander, U.S. Public Health Service Behavioral Health Consultant, Primary Care
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency
More informationSOUND ASLEEP: MEDICATIONS AND BEHAVIORAL STRATEGIES FOR OLDER ADULTS
SOUND ASLEEP: MEDICATIONS AND BEHAVIORAL STRATEGIES FOR OLDER ADULTS Jeannie Kim Lee, PharmD, BCPS, CGP, FASHP Colleges of Pharmacy and Medicine The University of Arizona Learning Objectives: Describe
More informationAnjali Ahn, MD Beth Israel Deaconess Medical Center May 1, 2015
Anjali Ahn, MD Beth Israel Deaconess Medical Center aahn1@bidmc.harvard.edu May 1, 2015 Ms G. is a 50yo female Boston police officer presents with chief complaint: I ve never been a good sleeper! Where
More informationSedative/Hypnotic Agents. Sedative/Hypnotic Agents. Central Nervous System Depressants. Sedative/Hypnotic Agents(cont d) Sleep
Central Nervous System Depressants Sedative Drugs that have an inhibitory effect on the CNS to the degree that they reduce: Nervousness, excitability, irritability Without causing sleep Hypnotics Calm
More informationSEDATIVE-HYPNOTIC AGENTS
SEDATIVE-HYPNOTIC AGENTS Documentation A. FDA approved indications 1. Insomnia 2. Sedation for an agitated patient in an inpatient setting Documentation B. Non-FDA approved, commonly used indications 1.
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More information11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides
Treatment for Anxiety Disorders Benzodiazepines and Other Anxiolytics Psychology 472 Pharmacology of Psychoactive Drugs Listen to the audio lecture while viewing these slides Ethanol Barbiturates and related
More informationHow to Manage Insomnia with and without medications
How to Manage Insomnia with and without medications Tatyana Gurvich, Pharm.D. USC School of Pharmacy UC Irvine SeniorHealth Center Insomnia: How common is it? 26-50% of adult population complain of insomnia
More informationAddressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling
Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Reference Number: CP.PMA_10.11.23 Effective Date: 07.16 Last Review Date: 04.18 Line of Business: Medicaid- Arizona (AHCS, CIC) Revision Log See Important Reminder
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More informationInsomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D
St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4
More informationSedatii WITH ANTI. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. Sedatii WITH ANTI Copyright Dowden Health Media For personal use only Initiate the antipsychotic at a reasonable, not
More informationInsomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier
Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how
More informationInsomnia. Stages of sleep. Insomnia: Catching Your ZZZs
Insomnia: Catching Your ZZZs Troy Payne MD, FAASM Medical Director, St. Cloud Hospital Sleep Center Diplomate of the American Academy of Psychiatry and Neurology in the Subspecialty of Sleep Medicine Insomnia
More informationRuby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018
Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018 Objectives Describe pharmacology of commonly prescribed drugs for stimulants and hypnotics Brief review of common drugs that affect sleep
More informationContinuing Education
Continuing Education Insomnia: Overview and Treatment Authors: Mitchell D. Clark Pharm.D. Candidate 2017 Harrison School of Pharmacy, Auburn University Katherine F. King Pharm.D. Candidate 2017 Harrison
More informationANTIANXIETY DRUGS: BENZODIAZEPINES
Margaret Gnegy Professor of Pharmacology pgnegy@umich.edu 1 ANTIANXIETY DRUGS: BENZODIAZEPINES Sedatives and hypnotics M. Gnegy, Ph.D. 1 2 Reading: Goodman & Gilman, 11th ed. Chapter 16, pp. 401-427. Drug
More informationAmbien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that
22-10-2013 Ambien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that can be treated with Ambien vs Rozerem. Ambien:. Ramelteon
More informationSedative / Hypnotics
Sedative / Hypnotics David H. Rubin, MD Executive Director, Massachusetts General Hospital Psychiatry Academy Director of Child and Adolescent Psychiatry Residency Training Massachusetts General Hospital
More informationCan you take sleeping pills with ativan
Cari untuk: Cari Cari Can you take sleeping pills with ativan 30-5-2015 Can 't sleep? Consumer Reports Best Buy Drugs explains why the Best Insomnia Treatment Is Not A Drug. 2-3-2018 Sleeping Pills: What
More informationSleep Clinic Case: History. Insomnia in Patients with Comorbid Psychiatric Disorders: Shared Neurobiology and Clinical Solutions
Sleep Clinic Case: History Insomnia in Patients with Comorbid Psychiatric Disorders: Shared Neurobiology and Clinical Solutions David N. Neubauer, MD Associate Professor Johns Hopkins University School
More informationSLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla
SLEEP-WAKE DISORDERS: INSOMNIA Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS AND ICD-10 Chapter V: Mental and Behavioural Disorders F51. Non-organic sleep disorders Chapter VI: Nervous System Illnesses G47.
More informationYou May Be at Risk. You are taking one of the following sedative-hypnotic medications: Diazepam (Valium ) Estazolam. Flurazepam.
You May Be at Risk You are taking one of the following sedative-hypnotic medications: Alprazolam (Xanax ) Diazepam (Valium ) Temazepam (Restoril ) Chlorazepate Estazolam Triazolam (Halcion ) Chlordiazepoxide
More informationIndex 265. Feeding bottle, 37 methods, 37
Index 263 Index A Actigraphy delayed sleep phase syndrome, 66f Activity, 19 Adenoidectomy OSAHS, 121 Adolescents insomnia, 71 81 assessment and treatment, 76 78 etiology, 75, 76 female, 74, 75 sleep need
More informationCBT for Insomnia: Past, Present, and Future Directions
CBT for Insomnia: Past, Present, and Future Directions J. Todd Arnedt, Ph.D. Associate Professor of Psychiatry and Neurology Director, Behavioral Sleep Medicine Program Acting Director, Sleep and Circadian
More informationSleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER
Sleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER Disclosure: Financial - none Non-Financial - none Selected Topics Sleep epidemiology Sleep
More informationDr Alex Bartle. Sleep Well Clinic
Dr Alex Bartle Sleep Well Clinic Overview of Sleep Disorders Sleep: Why bother. Effect of Poor Quality or reduced Quantity of Sleep Common Sleep Disorders Management of Insomnia Medication vs CBTi Conclusion
More informationWhat is sleep? o Sleep is a body s rest cycle.
What is sleep? o Sleep is a state when our senses and motor actvity are relatively suspended; there is a total or partial unconsciousness and all voluntary muscles are inactive. o Sleep is a body s rest
More informationSleeping Pills and Natural Sleep Aids
Sleeping Pills and Natural Sleep Aids Prescription and Over-the-Counter Products It s the middle of the night, and you re staring at the ceiling, thinking about work, or bills, or the kids. Sleep just
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.HNMC.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationA MORE DETAILED LOOK AT ANXIETY DISORDERS WILBUR DATTILO, MD ASSISTANT PROFESSOR OF PSYCHIATRY UNIVERSITY OF UTAH
A MORE DETAILED LOOK AT ANXIETY DISORDERS WILBUR DATTILO, MD ASSISTANT PROFESSOR OF PSYCHIATRY UNIVERSITY OF UTAH Special Thanks 2 Source: https://www.slideshare.net/lucia_merino/anxiety-disorders-dsm5-41189388
More informationDefinitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months
Chronic Definitions Alon Y. Avidan, M.D., M.P.H UCLA Sleep Disorders Center Is a Distinct Disorder That Should Be Treated NIH (1983) 1 NIH (2005) 2 is a symptom, is a disorder not a disorder DSM-5 INSOMNIA
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.CPA.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at
More informationYou May Be at Risk. You are taking one of the following sedative-hypnotic medications:
You May Be at Risk You are taking one of the following sedative-hypnotic medications: Alprazolam (Xanax ) Bromazepam (Lectopam ) Chlorazepate Chlordiazepoxideamitriptyline Clidinium-chlordiazepoxide Clobazam
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationBenzodiazepines 2015
Benzodiazepines 2015 Dual Disorders Ward Lev-Hasharon Mental Health Medical Center Netanya Israel 050-626-7912 alerner@lev-hasharon.co.il State of Israel Ministry of Health Lev-Hasharon Mental Health Medical
More informationSleep Disorders in the Psychiatric Context
Sleep Disorders in the Psychiatric Context John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor
More informationAnxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming
More informationDSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)
DSM-5 INSOMNIA 3 nights/wk 3 months Difficulty Falling Asleep: > 30 minutes Difficulty Maintaining Sleep Next Day Consequences Early AM awakenings: (> 30 minutes before desired wake time) Initiation Trouble
More informationSleep & Chronic Pain/Depression
Sleep & Chronic Pain/Depression BC Professor, University of Massachusetts Lowell As promised, these are the slides from my presentation at CPI which were not included in the distributed slides. BC 1 Sleep,
More informationTRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE
TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI
More informationUnderstanding Alzheimer s Disease
Understanding Alzheimer s Disease Alzheimer s disease is an irreversible, progressive brain disorder that slowly impacts memory, thinking, skills and, eventually, the ability to carry out the simplest
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationAnxiety& Depression in Primary Care- a Pharmacology Primer. Lisa Deloris Slade, DNP, MSN, FNP-BC North Carolina NP Spring Symposium March 27, 2017
Anxiety& Depression in Primary Care- a Pharmacology Primer Lisa Deloris Slade, DNP, MSN, FNP-BC North Carolina NP Spring Symposium March 27, 2017 Objectives Describe pharmacology, treatment considerations,
More informationLearning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017
Learning Objectives Characterize insomnia and its negative effects Management of Insomnia Discuss the goals of treatment Summarize guidelines of management of insomnia including non-pharmacologic and pharmacologic
More information48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014
48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationLEARNING OBJECTIVES SLEEP APNEA
LEARNING OBJECTIVES List key differences between insomnia and obstructive sleep apnea Identify at least two appropriate pharmacologic treatment options for insomnia INSOMNIA VS. SLEEP APNEA Morganne Smyth,
More informationModern Management of Sleep Disorders
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationInsomnia Treatment in Brief
Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep
More informationInsomnia Pearls in the Geriatric Population
Insomnia Pearls in the Geriatric Population September 9, 2016 Stephanie Loegering, PharmD, CGP Clinical Pharmacist VA Medical Center Thank You MPhA Wi-fi Information: NETWORK: EC-CTR PASSWORD: westgate252
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationInsomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)
10-15% of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 30 40% of adults complain of insomnia symptoms only 95% experience insomnia at some time in their
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationInsomnia. Dr Terri Henderson MBChB FCPsych
Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationSleep & Chronic Pain/Depression. Professor, University of Massachusetts Lowell
Sleep & Chronic Pain/Depression G ff Philli M E PhD PMHCNS BC Geoffry Phillips McEnany, PhD, PMHCNS, BC Professor, University of Massachusetts Lowell As promised, these are the slides from my presentation
More informationYour sleep is a reflection of your life
Sleep Disorders and Developmental Disabilities Rafael Pelayo, MD Do you really want to sleep like a baby? He/She won t sleep What goes through your mind when you hear this?? Your life is reflected in your
More informationAdisheartening aspect of all neurologic disorders. By Zac Haughn, Associate Editor. Type Casting
28 Practical Neurology July 2008 By Zac Haughn, Associate Editor Adisheartening aspect of all neurologic disorders is that the patient s ailment will be there waiting for them in the morning. Be it Alzheimer
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationThe Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State
The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State RAI/MDS Coordinator Objectives Upon completion of this training,
More informationSession 6. A good laugh and a long sleep are the best cures in the doctor's book. ~Irish Proverb
Session 6 Relaxation Response: Guided Imagery with an Inner Healer Check-in: 1. Share two items from your gratitude journal 2. Any changes in your diet since we have been talking about nutrition? Any results?
More information9/17/2015 DIAGNOSTIC PUZZLES LEARNING OBJECTIVES MENTAL ILLNESS MEDICAL COMORBIDITIES
DIAGNOSTIC PUZZLES MENTAL ILLNESS MEDICAL COMORBIDITES SUBSTANCE ABUSE SPECIAL POPULATIONS IMPROVING COMPLIANCE CASE STUDIES LEARNING OBJECTIVES Learner will be able to identify substance abuse and state
More informationEarl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles
Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Sleep Disorders Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) Sleep
More information